Pacira Biosciences
PCRX
#6251
Rank
$1.00 B
Marketcap
$25.50
Share price
-1.07%
Change (1 day)
15.04%
Change (1 year)
Categories

Operating Margin for Pacira Biosciences (PCRX)

Operating Margin as of July 2026 (TTM): 1.79%

According to Pacira Biosciences 's latest financial reports and stock price the company's current Operating Margin is 1.79%. At the end of 2025 the company had an Operating Margin of 4.33%.

Operating Margin history for Pacira Biosciences from 2010 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
20254.33%-161.16%
2024-7.09%-160.53%
202311.71%59.7%
20227.33%-53.52%
202115.77%55.39%
202010.15%282.43%
20192.65%-55%
20185.90%-165.5%
2017-9.00%-20.75%
2016-11.36%-406.45%
20153.71%-224.51%
2014-2.98%-95.59%
2013-67.43%-47.78%
2012-129.14%-47.44%
2011-245.70%54.29%
2010-159.25%-16.29%
2009-190.24%-41.6%
2008-325.77%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Zogenix
ZGNX
-259.55%-14,600.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
4.99% 179.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-467.67%-26,226.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-79.07%-4,517.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-20.52%-1,246.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-879.80%-49,250.84%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.